San Mateo, CA, United States of America

Daniel Gordon Michael Shore

USPTO Granted Patents = 2 

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):

Title: The Innovations of Daniel Gordon Michael Shore

Introduction

Daniel Gordon Michael Shore is an accomplished inventor based in San Mateo, California. He has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for cancer. With one patent to his name, Shore exemplifies innovation in the medical research industry.

Latest Patents

Shore's notable patent focuses on Polo Like Kinase 4 (PLK4) inhibitors. The patent, which includes compounds of Formula (I) or pharmaceutically acceptable salts thereof, presents a novel approach to treating cancer. These inhibitors are crucial as they target a specific kinase involved in cellular processes, thereby offering potential therapeutic benefits. The patent also covers pharmaceutical compositions that combine these compounds with acceptable excipients, enhancing their effectiveness in medical applications.

Career Highlights

Currently, Daniel Gordon Michael Shore is affiliated with Oric Pharmaceuticals, Inc., a respected name in the pharmaceutical sector. His work contributes to the company's mission of developing innovative therapies, particularly for patients with cancer and other serious diseases. Shore's dedication to research and development is evident in his commitment to exploring groundbreaking treatments.

Collaborations

Throughout his career, Shore has collaborated with skilled professionals like Chudi Ndubaku and Jared Moore. These partnerships are essential for fostering a creative environment that drives innovation and leads to the development of successful therapeutic solutions. Working alongside talented colleagues allows for the exchange of ideas and expertise, strengthening the overall impact of their research.

Conclusion

Daniel Gordon Michael Shore stands as a testament to the importance of innovation in the medical industry. With his pioneering work on PLK4 inhibitors, he continues to pave the way for advancements in cancer treatment. His achievements, combined with collaborative efforts at Oric Pharmaceuticals, Inc., underscore the vital role of inventors in transforming scientific research into effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…